- Home
- OGEN vs SBLX Comparison
OGEN vs SBLX Comparison
Compare OGEN & SBLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OGEN | SBLX |
|---|---|---|
| Founded | 1996 | 2017 |
| Country | United States | United States |
| Employees | N/A | 58 |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6M | 3.7M |
| IPO Year | 2010 | N/A |
Fundamental Metrics
Financial Performance| Metric | OGEN | SBLX |
|---|---|---|
| Price | $0.75 | $2.75 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 537.8K | 118.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.11 | $2.11 |
| 52 Week High | $9.16 | $7.85 |
Technical Indicators
Market Signals| Indicator | OGEN | SBLX |
|---|---|---|
| Relative Strength Index (RSI) | 44.27 | 55.56 |
| Support Level | $0.61 | $2.26 |
| Resistance Level | $0.90 | $3.01 |
| Average True Range (ATR) | 0.10 | 0.29 |
| MACD | -0.00 | 0.05 |
| Stochastic Oscillator | 3.86 | 79.22 |
Price Performance
Historical ComparisonAbout OGEN Oragenics Inc.
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.
About SBLX StableX Technologies Inc.
StableX Technologies Inc designs and manufactures compact, sustainable electric vehicles for closed campus mobility, low-speed urban and community transport, local on-demand and last-mile delivery, and government use. It operates as one reportable segment, focusing on the manufacturing and sales of environmentally-conscious, minimal-footprint EVs.